![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 9/64 | |
C12N 15/57 | |||
C07K 16/40 | |||
C12N 5/10 | |||
G01N 33/563 | |||
A61K 38/48 |
(11) | Number of the document | 1346034 |
(13) | Kind of document | T |
(96) | European patent application number | 01997546.5 |
Date of filing the European patent application | 2001-11-20 | |
(97) | Date of publication of the European application | 2003-09-24 |
(45) | Date of publication and mention of the grant of the patent | 2009-02-18 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2001/013391 |
Date | 2001-11-20 |
(87) | Number | WO 2002/042441 |
Date | 2002-05-30 |
(30) | Number | Date | Country code |
721254 | 2000-11-22 | US | |
833328 | 2001-04-12 | US |
(72) |
LAEMMLE, Bernhard, CH
SCHALLER-GERRITSEN, Helena, Elisabeth, CH
FURLAN, Miha, CH
TURECEK, Peter, AT
SCHWARZ, Hans-Peter, AT
SCHEIFLINGER, Friedrich, AT
ANTOINE, Gerhard, AT
KERSCHBAUMER, Randolf, AT
TAGLIAVACCA, Luigina, IT
ZIMMERMANN, Klaus, AT
VOELKEL, Dirk, AT
|
(73) |
Baxter Innovations GmbH,
Industriestrasse 67, 1221 Wien,
AT
|
(54) | VON WILLEBRAND FACTOR (vWF) CLEAVING PROTEASE POLYPEPTIDE, NUCLEIC ACID ENCODING THE POLYPEPTIDE AND USE OF POLYPEPTIDE |
VON WILLEBRAND FACTOR (vWF) CLEAVING PROTEASE POLYPEPTIDE, NUCLEIC ACID ENCODING THE POLYPEPTIDE AND USE OF POLYPEPTIDE |